SAN-711

N/A

Report date: 2025/03/14 15:13:24
NMEFirst In Class

Base Information

Drug NameSAN-711
Drug Alias NameSAN-711SAN711GABAA-α3-PAMACP-711
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGamma-aminobutyric acid A receptor alpha-3 modulators
TargetsGamma-aminobutyric acid A receptor alpha-3
Therapy Area/IndicationsPruritusNeuralgiaEpilepsy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesSaniona A/S
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsEpilepsy
Inactive IndicationsPruritusNeuralgia

Other Information

ATC CodeN/A
Related LinksN/A